BR9708049A - Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo - Google Patents

Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo

Info

Publication number
BR9708049A
BR9708049A BR9708049A BR9708049A BR9708049A BR 9708049 A BR9708049 A BR 9708049A BR 9708049 A BR9708049 A BR 9708049A BR 9708049 A BR9708049 A BR 9708049A BR 9708049 A BR9708049 A BR 9708049A
Authority
BR
Brazil
Prior art keywords
cells
kill
kit
population
immunotoxin
Prior art date
Application number
BR9708049A
Other languages
English (en)
Inventor
Oystein Fodstad
Gunnar Kvalheim
Meng Yu Wang
Olav Engebraten
Siri Juell
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Publication of BR9708049A publication Critical patent/BR9708049A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9708049A 1996-03-13 1997-03-12 Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo BR9708049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller
PCT/NO1997/000074 WO1997033611A1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins

Publications (1)

Publication Number Publication Date
BR9708049A true BR9708049A (pt) 1999-07-27

Family

ID=19899150

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708049A BR9708049A (pt) 1996-03-13 1997-03-12 Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo

Country Status (18)

Country Link
US (1) US7198787B2 (pt)
EP (1) EP0954329B1 (pt)
JP (1) JP2000507230A (pt)
CN (1) CN1218411A (pt)
AT (1) ATE222122T1 (pt)
AU (1) AU710184B2 (pt)
BR (1) BR9708049A (pt)
CA (1) CA2248620A1 (pt)
DE (1) DE69714775T2 (pt)
HU (1) HUP9901597A3 (pt)
IL (1) IL126014A0 (pt)
NO (1) NO961031D0 (pt)
NZ (1) NZ331763A (pt)
PL (1) PL328804A1 (pt)
RU (1) RU2182493C2 (pt)
SK (1) SK125798A3 (pt)
TR (1) TR199801795T2 (pt)
WO (1) WO1997033611A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US7496291B2 (en) * 2006-03-21 2009-02-24 Hewlett-Packard Development Company, L.P. Method and apparatus for interleaved image captures
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP3751005A3 (en) 2008-09-20 2021-02-24 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
MX2011004082A (es) * 2008-10-17 2011-10-14 Dana Farber Cancer Inst Inc Peptidos de dominio citoplasmico muc-1 como inhibidores del cancer.
JP5702371B2 (ja) 2009-05-27 2015-04-15 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｍｕｃ１のアンタゴニストを使用した、炎症の阻害
CN102127148B (zh) * 2010-01-14 2013-04-03 中国农业科学院北京畜牧兽医研究所 血管内皮细胞表面决定簇部分多肽及其应用
WO2012154530A1 (en) * 2011-05-06 2012-11-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Recombinant immunotoxin targeting mesothelin
CN107748256B (zh) * 2017-10-11 2020-04-14 厦门骁科码生物科技有限公司 一种循环肿瘤细胞的液体活检检测方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219411A (en) 1978-09-18 1980-08-26 California Institute Of Technology Cell sorting apparatus
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4510244A (en) 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4920061A (en) 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4752569A (en) 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
US5019497A (en) 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4710472A (en) 1985-09-25 1987-12-01 The United States Of America As Represented By The Secretary Of The Navy Magnetic separation device
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
EP0241042A3 (en) 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4857452A (en) 1986-12-04 1989-08-15 E. I. Du Pont De Nemours And Company Assay for carcinoma of breast, colon and ovary
US5194300A (en) 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
US5322678A (en) 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
FR2638848B1 (fr) 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
ES2067018T3 (es) 1988-12-28 1995-03-16 Stefan Miltenyi Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos.
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
WO1990010692A1 (en) 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia
US5081030A (en) 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
DE3919923A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
DE69033631T2 (de) * 1989-12-14 2001-05-17 Sloan Kettering Inst Cancer Therapeutische verwendungen der hypervariablen region des monoklonalen antikörpers m195 und konstrukte davon
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
GB9007966D0 (en) 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
JPH05107249A (ja) 1991-02-04 1993-04-27 Toyobo Co Ltd リガンド・レセプター反応の高感度検出法
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
AU2115092A (en) 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
DE69301725T2 (de) 1992-03-20 1996-07-25 Celsis Int Plc Verfahren und gerät zur analyse von biologischem material
US5422277A (en) 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
AU678179B2 (en) * 1992-07-28 1997-05-22 Steven Kessler Methods for positive immunoselection of stem cells
ES2123063T3 (es) 1992-09-14 1999-01-01 Stanford Res Inst Int Marcadores convertidores al alza para ensayos biologicos y otros mediante tecnicas de excitacion laser.
AU2593192A (en) 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
AUPN214095A0 (en) 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
EP0954329B1 (en) 2002-08-14
PL328804A1 (en) 1999-02-15
RU2182493C2 (ru) 2002-05-20
NO961031D0 (no) 1996-03-13
US7198787B2 (en) 2007-04-03
AU2522997A (en) 1997-10-01
HUP9901597A2 (hu) 1999-08-30
IL126014A0 (en) 1999-05-09
EP0954329A1 (en) 1999-11-10
CA2248620A1 (en) 1997-09-18
TR199801795T2 (xx) 1998-12-21
CN1218411A (zh) 1999-06-02
US20020151689A1 (en) 2002-10-17
AU710184B2 (en) 1999-09-16
DE69714775D1 (de) 2002-09-19
JP2000507230A (ja) 2000-06-13
ATE222122T1 (de) 2002-08-15
SK125798A3 (en) 1999-05-07
WO1997033611A1 (en) 1997-09-18
DE69714775T2 (de) 2003-04-24
HUP9901597A3 (en) 2000-06-28
NZ331763A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
BR9708049A (pt) Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo
IL132798A0 (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
BR0207722A (pt) Material compósito de enxerto de medula óssea, método de preparação do mesmo, e, kit para a preparação do mesmo
EA200000563A1 (ru) Способы лечения женщин в постклимактерическом состоянии с применением ультранизких доз эстрогена
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
EP1100870A4 (en) ENHANCING CARDIAC FUNCTIONING BY TRANSPLANTATION OF MESENCHYMAL STEM CELLS
ES2185705T3 (es) Proteina bifuncional, preparacion y uso.
DE69941903D1 (de) Behandlung von patienten die eine knochenmarktransplantation oder eine transplantation peripherer blutstammzellen erhalten mit anti-cd20 antikörpern
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
EA199900486A1 (ru) Применение сфингомиелиназы для повышения уровней церамидов в коже и слизистых оболочках, а также содержащие ее дерматологические и косметические композиции, которые удобны для местного применения
DK1294414T3 (da) Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
DE69738753D1 (de) AUF TGF-beta 1 ANSPRECHENDE KNOCHENMARKZELLEN
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
EA200100342A1 (ru) Связывающие соединения адгезионной молекулы нервной клетки
ES2054612T3 (es) Secuencias de adn que codifican para proteinas con actividad biologica de los inhibidores husi tipo-i y procedimientos tecnologicos geneticos para la preparacion de estas proteinas.
EA200001130A1 (ru) Промотор гена вмп-7 человека и способ анализа с его использованием вещества, связанного с костной тканью
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma
WO2003029432A3 (en) Human mesenchymal progenitor cell
NO984175L (no) FremgangsmÕte til Õ drepe mÕlceller i h°stede cellepopulasjoner med en eller flere immunotoksiner

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C12N 5/00 (2006.01), A61K 47/68 (2017.0